(Q3)Jul 31, 2024 | (Q2)Apr 30, 2024 | (Q1)Jan 31, 2024 | (FY)Oct 31, 2023 | (Q4)Oct 31, 2023 | (Q3)Jul 31, 2023 | (Q2)Apr 30, 2023 | (Q1)Jan 31, 2023 | (FY)Oct 31, 2022 | (Q4)Oct 31, 2022 | |
---|---|---|---|---|---|---|---|---|---|---|
Operating Cash Flow (Indirect Method) | ||||||||||
Cash flow from continuing operating activities | 71.74%-56.21K | -18.19%-540.7K | 71.19%-135.59K | -45.42%-1.4M | 22.69%-276.21K | -1.92%-198.92K | -111.76%-457.47K | -139.51%-470.61K | -40.47%-964.97K | -22.04%-357.26K |
Net income from continuing operations | -87.29%-457.16K | -421.64%-705.86K | 45.10%-417K | 0.18%-1.08M | 9.70%-291.19K | -294.16%-244.09K | 142.71%219.46K | -324.06%-759.58K | -132.85%-1.08M | 1.81%-322.47K |
Depreciation and amortization | --0 | --0 | 114.78%15.75K | 344.23%38.42K | 141.44%17.66K | 450.72%6.92K | 17,472.97%6.5K | 18,705.13%7.33K | 433.50%8.65K | 739.95%7.32K |
Asset impairment expenditure | --0 | ---- | ---- | -90.03%32.01K | 4,353.33%12.76K | -97.86%117 | ---- | ---- | --320.97K | ---300 |
Unrealized gains and losses of investment securities | --256.9K | --353.13K | --12.19K | ---311.53K | ---- | ---- | --0 | --0 | --0 | ---- |
Remuneration paid in stock | --75.32K | --0 | --0 | --448.26K | --0 | --0 | --0 | --448.26K | --0 | --0 |
Other non cashItems | -29.95%-178.09K | --29.51K | --27.61K | -64.52%-431.57K | 2,340.46%358.85K | ---137.04K | ---- | ---- | -4.38%-262.32K | -136.12%-16.02K |
Change In working capital | 40.90%246.82K | -342.16%-217.48K | 235.55%225.86K | -329.45%-103.41K | -143.40%-62.77K | 64.76%175.17K | -172.45%-49.19K | -857.06%-166.63K | 259.38%45.07K | 46.56%-25.79K |
-Change in receivables | -84.18%4.43K | 93.06%-3.34K | 79.64%42.02K | 117.16%8.13K | 109.08%4.75K | 2.80%28.01K | -929.03%-48.03K | 232.81%23.39K | -1,004.99%-47.38K | -248.54%-52.35K |
-Change in prepaid assets | -58.07%29.24K | 147.04%18.16K | 158.27%50.76K | -8,807.87%-79.68K | -5.51%-23.71K | 197.28%69.74K | -386.82%-38.6K | -543.59%-87.1K | 108.81%915 | -298.37%-22.47K |
-Change in payables and accrued expense | 175.30%213.15K | -720.44%-232.31K | 229.31%133.08K | -134.81%-31.87K | -189.37%-43.82K | 39.22%77.43K | 239.47%37.44K | -849.17%-102.91K | 772.71%91.54K | 162.97%49.03K |
Cash from discontinued investing activities | ||||||||||
Operating cash flow | 71.74%-56.21K | -18.19%-540.7K | 71.19%-135.59K | -45.42%-1.4M | 22.69%-276.21K | -1.92%-198.92K | -111.76%-457.47K | -139.51%-470.61K | -40.47%-964.97K | -22.04%-357.26K |
Investing cash flow | ||||||||||
Cash flow from continuing investing activities | -44.70%-203.48K | -109.44%-50.25K | 59.93%-74.25K | 0.85%61.97K | -298.74%-144.35K | -307.70%-140.62K | 482.53%532.25K | -209.60%-185.32K | 112.28%61.44K | 80.91%-36.2K |
Capital expenditure reported | ---- | 57.03%-50.25K | 83.77%-69.52K | ---- | ---- | ---- | 64.60%-116.94K | -187.86%-428.25K | ---- | ---- |
Net PPE purchase and sale | -78.46%205.09K | --0 | 84.64%-4.73K | ---66.23K | -62.34%-1.39M | 11.44%952.34K | 225.70%399.55K | -109.69%-30.81K | --0 | -544.65%-854.57K |
Net other investing changes | ---- | ---- | ---- | 108.63%128.19K | --1.24M | ---1.64M | --249.65K | --273.74K | --61.44K | ---- |
Cash from discontinued investing activities | ||||||||||
Investing cash flow | -44.70%-203.48K | -109.44%-50.25K | 59.93%-74.25K | 0.85%61.97K | -298.74%-144.35K | -307.70%-140.62K | 482.53%532.25K | -209.60%-185.32K | 112.28%61.44K | 80.91%-36.2K |
Financing cash flow | ||||||||||
Cash flow from continuing financing activities | -431.62%-33.32K | 23,346.77%765.98K | 614.43%29.49K | -54.41%538.68K | -53.11%553.98K | -6.27K | -3.3K | -5.73K | 15.18%1.18M | -3.61%1.18M |
Net issuance payments of debt | -431.62%-33.32K | 2,383.40%136.89K | -118.30%-12.51K | 6,055.34%535.98K | 6,255.29%553.98K | ---6.27K | ---6K | ---5.73K | 95.50%-9K | ---9K |
Net common stock issuance | --0 | ---- | ---- | --0 | ---2.7K | --0 | ---- | ---- | -2.88%1.19M | ---- |
Proceeds from stock option exercised by employees | ---- | ---- | ---- | --2.7K | ---- | ---- | ---- | ---- | --0 | --0 |
Net other financing activities | ---- | ---- | --42K | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
Cash from discontinued financing activities | ||||||||||
Financing cash flow | -431.62%-33.32K | 23,346.77%765.98K | 614.43%29.49K | -54.41%538.68K | -53.11%553.98K | ---6.27K | ---3.3K | ---5.73K | 15.18%1.18M | -3.61%1.18M |
Net cash flow | ||||||||||
Beginning cash position | -39.87%328.31K | -67.70%153.28K | -70.64%333.62K | 32.39%1.14M | -42.49%200.21K | 14.80%546.02K | -42.88%474.54K | 32.39%1.14M | -15.84%858.2K | 203.47%348.13K |
Current changes in cash | 15.27%-293.01K | 144.85%175.03K | 72.74%-180.35K | -388.70%-802.57K | -83.07%133.42K | -171.27%-345.81K | 120.13%71.49K | -2,314.20%-661.66K | 272.08%278K | 6.00%788.06K |
End cash Position | -82.37%35.29K | -39.87%328.31K | -67.70%153.28K | -70.64%333.62K | -70.64%333.62K | -42.49%200.21K | 14.80%546.02K | -42.88%474.54K | 32.39%1.14M | 32.39%1.14M |
Free cash from | -79.60%63.53K | -2.80%-590.95K | 77.43%-209.84K | -52.28%-1.47M | -169.16%-276.42K | 165.86%311.52K | -5.21%-574.87K | -169.27%-929.67K | 43.19%-964.97K | 158.93%399.66K |
Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
Audit Opinions | -- | -- | -- | Unqualified Opinion with Explanatory Notes | -- | -- | -- | -- | Unqualified Opinion with Explanatory Notes | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.
No Data